SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(5.10%),Steven Boyd(5.10%)
Protagenic Therapeutics | 4:持股变动声明-董事 WRIGHT TIMOTHY R
Protagenic Therapeutics | 4:持股变动声明-董事 Stein Robert Benjamin
Protagenic Therapeutics | 4:持股变动声明-董事 Barrage Khalil
Protagenic Therapeutics | 4:持股变动声明-董事 Buell Jennifer
Protagenic Therapeutics | 4:持股变动声明-高管 ARMEN GARO H
Protagenic Therapeutics | 4:持股变动声明-董事 Corvese Brian
Protagenic Therapeutics | 4:持股变动声明-高管 Arrow Alexander K.
Protagenic Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(5.13%),Steven Boyd(5.13%)
Protagenic Therapeutics | 4:持股变动声明-首席财务官 Arrow Alexander K.
Protagenic Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(5.26%),Steven Boyd(5.26%)
Protagenic Therapeutics | 4:持股变动声明
Protagenic Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(5.4%),Steven Boyd(5.4%)
Protagenic Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)
Protagenic Therapeutics | 4:持股变动声明
Protagenic Therapeutics | 4:持股变动声明
Protagenic Therapeutics | 4:持股变动声明
Protagenic Therapeutics | 4:持股变动声明
Protagenic Therapeutics | 4:持股变动声明
Protagenic Therapeutics | 4:持股变动声明